Skip to main content

Client News

InflaRx Announces Commercial Launch of Gohibic (vilobelimab) in the U.S. for the Treatment of Critically Ill COVID-19 Patients

21st June 2023

Mainz Biomed Expands into Romania through Partnership with Bioclinica

20th June 2023

invIOs presents exciting preclinical data showing that immune-activating small molecule INV501 induces strong cytotoxic activity against solid tumors

19th June 2023

Abivax receives “Capital Market Transaction of the Year Award” at the European Mediscience Awards 2023

15th June 2023

Digital health start-up Capreolos GmbH launches Ready4OP app to support patients before major surgical procedures

15th June 2023

Medigene AG: Medigene to Host Virtual R&D Event on TCR-T Therapies for Solid Tumors

13th June 2023

ITM Opens World’s Largest Lutetium-177 Production Facility for Targeted Radionuclide Therapies Against Cancer

13th June 2023

Biotalys announces closing of private placement

12th June 2023

Abivax stock included in MSCI indexes

8th June 2023

Biotalys Strengthens Relationship with Investors via Private Placement of New Shares for €7 million

7th June 2023